CMV

COMMUNIQUÉS West-GlobeNewswire

SurgiBox Expands European Presence Through Strategic Partnership with Ondatec Medical in Türkiye
02/07/2025
CAMBRIDGE, Mass., July 02, 2025 (GLOBE NEWSWIRE) -- SurgiBox, Inc., a pioneering medical technology company dedicated to bringing safe surgery to every patient, today announced a strategic partnership with Ondatec [...]
Cronos Grows its International Footprint in Switzerland
02/07/2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS ® medical cannabis brand in [...]
AMN Healthcare Sells Smart Square Scheduling Technology to symplr, Creates Commercial Partnership to Deliver Comprehensive Healthcare Workforce Solutions
02/07/2025
Strategic Partnership Fosters Integration, Innovation in Healthcare Workforce Planning & Management DALLAS, July 02, 2025 (GLOBE NEWSWIRE) -- AMN Healthcare (NYSE: AMN), the leader in total healthcare talent [...]
Highest THCa Flower July 2025: New Hemp Hop Strains Hit the Market
02/07/2025
CHARLOTTE, N.C., July 02, 2025 (GLOBE NEWSWIRE) -- Hemp Hop has announced the launch of 2 new high-THCa strains - London Jealousy and Gravel Pit . As demand for the best exotic THCa flower continues to grow, Hemp Hop [...]
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
02/07/2025
PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods ® IBS inFoods ® IBS provides [...]
Extendicare Acquires Closing the Gap Healthcare Group
02/07/2025
Extendicare increases Senior Secured Credit Facility to $375 million MARKHAM, Ontario, July 02, 2025 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that its wholly owned [...]
Pneumagen Announces Peer-Reviewed Publication of Positive Phase II Study Data Highlighting the Potential of Neumifil, a Novel Broad-Spectrum Antiviral
02/07/2025
Pneumagen’s intranasal broad-spectrum antiviral therapy reduced infection, improved symptoms and severity and reduced viral load in a Phase II influenza study in data published in the high-impact, peer-reviewed [...]
AppleGate Recovery Unveils Brand Refresh Aligned with BayMark Health Services Continuum of Care
02/07/2025
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- AppleGate Recovery, a leading provider of office-based medication-assisted treatment (MAT) for substance use disorders, is proud to announce the launch of its [...]
Middlesex Recovery Unveils Brand Refresh to Reflect Unified Identity with BayMark Health Services
02/07/2025
LEWISVILLE, Texas, July 02, 2025 (GLOBE NEWSWIRE) -- Middlesex Recovery, a provider of office-based opioid treatment for substance use disorders, has introduced a brand refresh that reflects its alignment with BayMark [...]
PharmaTher Announces Path to Ketamine Commercialization with No Planned Financing, Confirms FDA Approval Goal Date of August 9th, 2025 for Ketamine
02/07/2025
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on the development and commercialization of [...]
Eyenovia Announces Rebranding and Corporate Name Change to Hyperion DeFi, Inc.
02/07/2025
Name change reflects company’s leadership position with its cryptocurrency treasury reserve strategy focused on the HYPE token Company to commence trading on Nasdaq under the symbol “HYPD” effective July 3rd Also [...]
VYNE Therapeutics Provides Program Update on Oral BET inhibitor VYN202
02/07/2025
BRIDGEWATER, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat [...]
BriaCell Highlights Additional Phase 3 Clinical Sites Including Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven
02/07/2025
Together, Los Angeles Cancer Network and Smilow Cancer Hospital at Yale New Haven add 30 satellite locations to enroll patients in BriaCell’s pivotal Phase 3 study BriaCell’s Phase 3 study currently has 58 active [...]
Abeona Therapeutics® Closes Sale of Rare Pediatric Disease Priority Review Voucher for $155 Million
02/07/2025
Cash resources totaled approximately $225 million as of June 30, 2025 CLEVELAND, July 02, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the closing of the sale of its Rare Pediatric [...]
Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025
02/07/2025
IRVINE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its second [...]
Invivyd and Leading Researchers Form SPEAR (Spike Protein Elimination and Recovery) Study Group to Assess the Effects of Monoclonal Antibody Therapy for Long COVID and COVID-19 Post-Vaccination Syndrome
02/07/2025
SPEAR Study Group initiated following multiple, independent reports of substantial clinical benefit associated with PEMGARDA ® (pemivibart) therapy among people with Long COVID SPEAR Study Group collaborators Drs. [...]
Dr. Oetker Takes the Stage with Suprema – A Sophisticated New Frozen Pizza Celebrated Through a Custom Opera Performance
02/07/2025
Custom opera. Premium pizza. A dramatic debut in downtown Toronto TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- To mark its boldest product launch in over two decades, Dr. Oetker Canada is introducing Suprema not just as a [...]
Dr. Oetker monte sur scène avec Suprema, une nouvelle pizza surgelée sophistiquée célébrée par un spectacle d'opéra personnalisé
02/07/2025
Opéra personnalisé. Pizza de qualité supérieure. Des débuts spectaculaires au centre-ville de Toronto TORONTO, 02 juill. 2025 (GLOBE NEWSWIRE) -- Pour marquer le lancement de son produit le plus audacieux en plus de [...]
Ligand Announces Completion of Pelthos Therapeutics Merger with Channel Therapeutics
02/07/2025
Pelthos plans to launch ZELSUVMI™ for the treatment of Molluscum contagiosum infections in July 2025 Concurrent with the closing of the merger, Ligand has invested $18 million in the combined company and is entitled to [...]

Pages